~~<i id='B212355A98'><strike id='B212355A98'><tt id='B212355A98'><pre id='B212355A98'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：focus 2025-10-02 23:32:03 - browse：16

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Doctors on social media are being harassed and cyberbullied

leisure time

focus

entertainment

explore

knowledge

leisure time

AdobeAkiliInteractive,whichin2020madewavesbyreceivingFoodandDrugAdministrationclearanceforitsvideoga

WSS

Why the drug industry's warnings on the IRA's impact fall short

What happened to the House vote on health price transparency?

White House Covid adviser calls on docs to combat misinformation

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Having children helps parents live longer, especially after age 80

House panel takes first step toward fixing drug shortages

leisure time

fashion

leisure time

Jerome Adams on the need for new antivirals for Covid

Bernie Sanders gets little from pharma CEOs on drug prices

How to save PrEP access — and even expand it

House panel takes first step toward fixing drug shortages

Guidelines to prevent youth baseball injuries need more muscle

Juul documents reveal insider tactics on political lobbying

Alkermes shareholders re

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Medical records are filled with copy

House panel takes first step toward fixing drug shortages

focus

Transgender sports debate: Physicians say bans are health issue

Websites selling Wegovy, Zepbound ingredients targeted by FDA

'A game

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

PBMs drew scrutiny in House hearing — and so did pharma

entertainment

explore

knowledge

leisure time